Source comparison
BPC-157 Research Longevity Considerations: Comparison
1–4 weeks (acute) Tendon repair, gastric ulcer healing, ligament injury Accelerated collagen deposition, reduced inflammatory markers, improved tensile strength at injury sites None. Studies end before chronic adaptation or senescence markers become relevant S
This comparison does not assign a generated winner or score.
- 1–4 weeks (acute)
- Tendon repair, gastric ulcer healing, ligament injury
- Accelerated collagen deposition, reduced inflammatory markers, improved tensile strength at injury sites
- None. Studies end before chronic adaptation or senescence markers become relevant
- Standard healing protocols measure recovery speed, not long-term tissue remodeling effects
- 4–12 weeks (subacute)
- Nerve regeneration, chronic inflammation models, extended injury recovery
- Improved nerve conduction velocity, sustained anti-inflammatory effects, normalized vascular function
- Minimal. One study measured oxidative stress markers at 8 weeks, found no adverse shift
- No measurement of mitochondrial function, cellular senescence (p16, p21 expression), or telomere length
- 12+ weeks (chronic)
- Regulatory toxicity studies only
- No organ toxicity, no carcinogenic signal, no reproductive harm at 10× therapeutic doses
- Standard toxicity panel (liver enzymes, kidney function, histopathology). Not aging biomarkers
- Zero published studies examining inflammaging markers, NAD+ metabolism, autophagy flux, or other longevity-specific pathways